Patent US3414635A successfully refreshed from Google Patents.
Patent US5045304A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5045304A Expired / Lapsed US ⏱️ 0.0 years remaining

Contras agent having an imaging agent coupled to viable granulocytes for use in magnetic resonance imaging of abscess and a method of preparing and using same

Assignee: Wayne State University
•
Filing: 1988-08-31
•
Granted: 1991-09-03
•
Expires: 2008-08-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method and contrast agent for magnetic resonance imaging (MRI) of abscess. Granulocytes are separated from whole blood and incubated with an imaging vehicle such as magnetite. The granulocytes encapsulate the imaging vehicle and are suspended in an intravascularly administrable carrier to form the contrast agent. The contrast agent is highly specific for MRI of abscess.

Inventors

  • 👤 David R. Schneider
  • 👤 Kostaki G. Bis

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 09:21
CPC Classifications
G; G01; G01R; G01R33/00; G01R33/20; G01R33/44; G01R33/48; G01R33/54; G01R33/56; G01R33/5601; A; A61; A61K; A61K49/00; A61K49/06; Y; Y10; Y10T; Y10T436/00; Y10T436/24

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 112 words
A method of preparing and using contrast agent in magnetic resonance imaging abscesses in a patient comprising the steps of: mixing a specific number of viable granulocytes with an aqueous solution of a metallic imaging agent in which said imaging agent binds to and is subsequently incorporated into the granulocytes incubating said aqueous solution to encapsulate said imaging agent in said granulocytes to form labeled granulocytes; separating said labeled granulocytes from said solution; suspending said labeled granulocytes in an intravascularly administerable carrier to form said contrast agent; administering a diagnostically effective amount of said contrast agent by intravenous infusion to said patient; and subjecting said patient to examination by magnetic resonance imaging.
Claim 2
Independent Claim 112 words
A method of preparing and using contrast agent in magnetic resonance imaging abscesses in a patient comprising the steps of: mixing a specific number of viable granulocytes with an aqueous solution of a metallic imaging agent in which said imaging agent binds to and is subsequently incorporated into the granulocytes incubating said aqueous solution to encapsulate said imaging agent in said granulocytes to form labeled granulocytes; separating said labeled granulocytes from said solution; suspending said labeled granulocytes in an intravascularly administerable carrier to form said contrast agent; administering a diagnostically effective amount of said contrast agent by intravenous infusion to said patient; and subjecting said patient to examination by magnetic resonance imaging.
Claim 3
Dependent Claim 23 words
The method of claim 1 wherein said separating step further comprises attracting said labelled granulocytes from said aqueous solution with a pole magnet.
Claim 4
Dependent Claim 22 words
The method of claim 1 further comprising after the separating step, the step of washing the labelled granulocytes with a physiologic buffer.
Claim 5
Dependent Claim 18 words
The method of claim 1 in which said imaging agent is a ferromagnetic metal or non-toxic salt thereof.
Claim 6
Dependent Claim 18 words
The method of claim 1 in which said imaging agent is a paramagnetic metal or non-toxic salt thereof.
Claim 7
Dependent Claim 18 words
The method of claim 1 in which said imaging agent is a superparamagnetic metal or non-toxic salt thereof.
Claim 8
Dependent Claim 17 words
The method of claim 1 in which said imaging agent is magnetite; Fe 2 O 3 .FeO.
Claim 9
Dependent Claim 19 words
The method of claim 1 in which the incubating step further comprises bubbling O 2 through said aqueous solution.
Claim 10
Dependent Claim 31 words
The method of claim 1 in which the imaging agent has the formula F 2 O 3 .XO, where X is one of the group consisting of para-magnetic and ferro-magnetic material.
Claim 11
Dependent Claim 59 words
A contrast reagent for MRI of abscesses, said reagent comprising: a suspension of labelled granulocytes in an intravascularly adminstrable carrier, said granulocytes binding to and subsequently incorporating within a diagnostically effective amount of an imaging agent, said agent having the formula Fe 2 O 3 .XO where X is one of the group consisting of para-magnetic and ferro-magnetic materials.
Claim 12
Dependent Claim 59 words
A contrast reagent for MRI of abscesses, said reagent comprising: a suspension of labelled granulocytes in an intravascularly adminstrable carrier, said granulocytes binding to and subsequently incorporating within a diagnostically effective amount of an imaging agent, said agent having the formula Fe 2 O 3 .XO where X is one of the group consisting of para-magnetic and ferro-magnetic materials.
Claim 13
Dependent Claim 17 words
The contrast agent of claim 10 wherein said imaging agent is magnetite; Fe 2 O 3 .FeO.
Claim 14
Dependent Claim 13 words
The contrast agent of claim 10 wherein said intravascularly adminsterable carrier is plasma.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-09-02 1995-03-04 1995-09-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-09-02 1999-03-04 1999-09-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-09-02 2003-03-04 2003-09-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag